University of Cape Town-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Cape Town - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013575
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Cape Town (UCT) is a public research university that offers educational services. The university offers services for faculty of commerce, faculty of engineering and the built environment, faculty of health sciences, faculty of humanities, faculty of law and faculty of science. It also offers undergraduate and postgraduate degree programmes across the faculties. The university also offers undergraduate and postgraduate diploma programmes. UCT also operates the Centre for Open Learning, which offers a range of courses for students, participants from commerce and industry, government departments, NGOs and the general public. UCT is headquartered in Cape Town, South Africa.

University of Cape Town – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Cape Town, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Cape Town, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Cape Town, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Cape Town, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Cape Town, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of Cape Town, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medicago Enters into Agreement with University of Cape Town 10
Novartis Institutes for BioMedical Research Enters into Co-Development Agreement with University of Cape Town 11
Asset Transactions 12
AngioDesign Acquires IP Rights from University of Cape Town 12
University of Cape Town – Key Competitors 13
University of Cape Town – Key Employees 14
University of Cape Town – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
University of Cape Town, Pharmaceuticals & Healthcare, Key Facts 2
University of Cape Town, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Cape Town, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Cape Town, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Cape Town, Deals By Therapy Area, 2011 to YTD 2017 8
University of Cape Town, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Medicago Enters into Agreement with University of Cape Town 10
Novartis Institutes for BioMedical Research Enters into Co-Development Agreement with University of Cape Town 11
AngioDesign Acquires IP Rights from University of Cape Town 12
University of Cape Town, Key Competitors 13
University of Cape Town, Key Employees 14
University of Cape Town, Subsidiaries 15

★海外企業調査レポート[University of Cape Town-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Narada Power Source Co Ltd (300068):企業の財務・戦略的SWOT分析
    Summary Narada Power Source Co Ltd (Narada Power) is a battery manufacturer and distributor that markets and supplies stored energy solutions. The company's products include eos series batteries, acme series, acmeG series, GP series, TTG series, TT series, eosG series, GPG series, MP series, HRL ser …
  • Gilead Sciences Inc (GILD):医療機器:M&Aディール及び事業提携情報
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務分析
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aaron’s Inc:企業の戦略・SWOT・財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Exicure Inc-製薬・医療分野:企業M&A・提携分析
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC, is a biotechnology company that develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid (SNA) constructs. Its technology portfolio includes SNA gene regulation platform and …
  • Interstate Hotels & Resorts Inc:企業のM&A・事業提携・投資動向
    Interstate Hotels & Resorts Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Interstate Hotels & Resorts Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Pacific Edge Ltd (PEB):製品パイプライン分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Probiodrug AG (PBD):企業の財務・戦略的SWOT分析
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Johnson Matthey PLC:企業の戦略・SWOT・財務情報
    Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report Summary Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hibbett Sports Inc:企業の戦略・SWOT・財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Polpharma SA:企業の戦略的SWOT分析
    Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • MISC Berhad:企業の戦略・SWOT・財務分析
    MISC Berhad - Strategy, SWOT and Corporate Finance Report Summary MISC Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Genentech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • Hitec Power Protection BV:企業の戦略的SWOT分析
    Hitec Power Protection BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Pakistan Water and Power Development Authority:発電所・企業SWOT分析
    Pakistan Water and Power Development Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Richelieu Hardware Ltd:企業の戦略・SWOT・財務情報
    Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report Summary Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆